• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣二次植入治疗先前植入人工瓣膜功能欠佳:文献综述

Second transcatheter aortic valve implantation for treatment of suboptimal function of previously implanted prosthesis: review of the literature.

作者信息

Witkowski Adam, Jastrzebski Jan, Dabrowski Maciej, Chmielak Zbigniew

机构信息

Interventional Cardiology and Angiology Department, Institute of Cardiology, Warsaw, Poland.

出版信息

J Interv Cardiol. 2014 Jun;27(3):300-7. doi: 10.1111/joic.12120. Epub 2014 Apr 15.

DOI:10.1111/joic.12120
PMID:24731263
Abstract

OBJECTIVES

To systematically review reported cases of second transcatheter aortic valve deployment within a previously implanted prosthesis (TAV-in-TAV).

BACKGROUND

TAV-in-TAV deployment is one of the rescue strategies undertaken due to an unsuccessful or suboptimal transcatheter aortic valve implantation (TAVI) result. Currently, there are no clear indications for second valve implantation and outcomes of patients with 2 prostheses deployed remain poorly known.

METHODS

The MEDLINE and PubMed databases were searched for cases of TAV-in-TAV implantations of aortic valve.

RESULTS

Forty-three articles reporting on TAV-in-TAV deployment were included in the review. The most frequently observed indication for second valve implantation was aortic regurgitation (AR) occurring shortly after TAVI. There was a strong dominance of paravalvular over intravalvular AR, with prosthesis malposition being the main underlying cause of TAVI failure (81% of all identified cases). Perioperative echocardiographic images are crucial in identifying causes of failure and helpful in optimal rescue strategy selection. Success rate of TAV-in-TAV implantation varies from 90% to 100% with mortality rate of 0-14.3% at 30 days. Despite similar aortic valve function in follow-up, TAV-in-TAV may be an independent predictor of increased cardiovascular mortality.

CONCLUSIONS

TAV-in-TAV implantation is feasible and results in favorable short- and mid-term outcomes in patients with acute failure of TAVI without recourse to open-heart surgery. Further studies are needed to establish algorithm of the management of unsuccessful or suboptimal implantation results.

摘要

目的

系统回顾已报道的在先前植入的人工心脏瓣膜内进行二次经导管主动脉瓣植入术(瓣中瓣)的病例。

背景

瓣中瓣植入术是因经导管主动脉瓣植入术(TAVI)结果不成功或不理想而采取的挽救策略之一。目前,二次瓣膜植入尚无明确指征,且植入两个人工瓣膜的患者的预后仍知之甚少。

方法

在MEDLINE和PubMed数据库中检索主动脉瓣瓣中瓣植入术的病例。

结果

该综述纳入了43篇关于瓣中瓣植入术的文章。二次瓣膜植入最常见的指征是TAVI后不久出现的主动脉瓣反流(AR)。瓣周漏导致的AR明显多于瓣内漏,人工瓣膜位置不当是TAVI失败的主要潜在原因(在所有已识别病例中占81%)。围手术期超声心动图图像对于确定失败原因至关重要,有助于选择最佳的挽救策略。瓣中瓣植入术的成功率在90%至100%之间,30天死亡率为0至14.3%。尽管随访时主动脉瓣功能相似,但瓣中瓣可能是心血管死亡率增加的独立预测因素。

结论

瓣中瓣植入术是可行的,对于TAVI急性失败且无需进行心脏直视手术的患者,可产生良好的短期和中期预后。需要进一步研究以建立处理不成功或不理想植入结果的算法。

相似文献

1
Second transcatheter aortic valve implantation for treatment of suboptimal function of previously implanted prosthesis: review of the literature.经导管主动脉瓣二次植入治疗先前植入人工瓣膜功能欠佳:文献综述
J Interv Cardiol. 2014 Jun;27(3):300-7. doi: 10.1111/joic.12120. Epub 2014 Apr 15.
2
Second valve implantation for the treatment of a malpositioned transcatheter aortic valve.
J Invasive Cardiol. 2012 Sep;24(9):457-62.
3
Valve-in-valve transcatheter aortic valve implantation: the new playground for prosthesis-patient mismatch.瓣中瓣经导管主动脉瓣植入术:人工瓣膜与患者不匹配的新领域。
J Interv Cardiol. 2014 Jun;27(3):287-92. doi: 10.1111/joic.12108. Epub 2014 Mar 10.
4
Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.北欧国家经导管主动脉瓣中瓣植入术的早期临床结果。
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1047-54; discussion 1054. doi: 10.1016/j.jtcvs.2013.06.045. Epub 2013 Aug 30.
5
Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.经导管植入第二代瓣膜治疗单纯主动脉瓣反流:手术结果、血流动力学数据及随访
Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):388-93. doi: 10.1093/icvts/ivu155. Epub 2014 Jun 3.
6
Treatment of Pure Aortic Regurgitation Using a Second-Generation Transcatheter Aortic Valve Implantation System.使用第二代经导管主动脉瓣植入系统治疗单纯主动脉瓣反流
J Am Coll Cardiol. 2016 Jun 14;67(23):2803-2805. doi: 10.1016/j.jacc.2016.03.568.
7
Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 2).经导管主动脉瓣植入术治疗失败的外科生物瓣主动脉瓣:从概念到临床应用和评估(第 2 部分)。
JACC Cardiovasc Interv. 2011 Jul;4(7):733-42. doi: 10.1016/j.jcin.2011.05.007.
8
Sutureless aortic valve replacement may improve early mortality compared with transcatheter aortic valve implantation: A meta-analysis of comparative studies.与经导管主动脉瓣植入术相比,无缝合主动脉瓣置换术可能降低早期死亡率:一项比较研究的荟萃分析。
J Cardiol. 2016 Jun;67(6):504-12. doi: 10.1016/j.jjcc.2015.09.009. Epub 2015 Oct 23.
9
Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.经股主动脉瓣置换术治疗症状性重度主动脉瓣狭窄时,爱德华兹·萨皮恩 3 号瓣比爱德华兹 XT 瓣更成功。
Arch Cardiovasc Dis. 2018 Aug-Sep;111(8-9):470-479. doi: 10.1016/j.acvd.2017.05.012. Epub 2017 Nov 8.
10
Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.经心尖途径使用 JenaValve™ 系统植入主动脉瓣膜:多中心 CE 标志研究的急性和 30 天结果。
Eur J Cardiothorac Surg. 2012 Jun;41(6):e131-8. doi: 10.1093/ejcts/ezs129. Epub 2012 Apr 16.

引用本文的文献

1
Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis.亚太心脏病学会关于经导管主动脉瓣植入术在主动脉瓣狭窄管理中应用的立场声明。
JACC Asia. 2024 Nov 1;4(12):885-897. doi: 10.1016/j.jacasi.2024.10.001. eCollection 2024 Dec.
2
Features and outcomes of bailout repeat transcatheter aortic valve implantation (TAVI): the Bailout Acute TAVI-in-TAVI to Lessen Events (BATTLE) international registry. bailout 重复经导管主动脉瓣置换术(TAVI)的特点和结局:Bailout Acute TAVI-in-TAVI to Lessen Events(BATTLE)国际注册研究。
Clin Res Cardiol. 2024 Jan;113(1):68-74. doi: 10.1007/s00392-023-02239-8. Epub 2023 Jun 9.
3
Collaborative work in a complex case of Fontan for treating intra-atrial reentrant tachycardia and severe aortic stenosis: a case report.
法洛四联症复杂病例中治疗房内折返性心动过速和重度主动脉瓣狭窄的协作治疗:一例报告
Eur Heart J Case Rep. 2023 Jan 31;7(2):ytad053. doi: 10.1093/ehjcr/ytad053. eCollection 2023 Feb.
4
The Use of BASILICA Technique to Prevent Coronary Obstruction in a TAVI-TAVI Procedure.在经导管主动脉瓣置换术(TAVI)-经导管主动脉瓣置换术过程中使用BASILICA技术预防冠状动脉阻塞。
J Clin Med. 2021 Nov 26;10(23):5534. doi: 10.3390/jcm10235534.
5
Advancements in Transcatheter Aortic Valve Implantation: A Focused Update.经导管主动脉瓣植入术的进展:重点更新。
Medicina (Kaunas). 2021 Jul 14;57(7):711. doi: 10.3390/medicina57070711.
6
Anatomical Predictors of Valve Malposition During Self-Expandable Transcatheter Aortic Valve Replacement.自膨胀式经导管主动脉瓣置换术中瓣膜位置异常的解剖学预测因素
Front Cardiovasc Med. 2021 Jul 12;8:600356. doi: 10.3389/fcvm.2021.600356. eCollection 2021.
7
How to Image and Manage Prosthesis-Related Complications After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后如何对人工瓣膜相关并发症进行成像及管理。
Curr Cardiol Rep. 2021 Jul 1;23(8):94. doi: 10.1007/s11886-021-01522-2.
8
New Insights into Valve Hemodynamics.瓣膜血流动力学的新见解
Rambam Maimonides Med J. 2020 Apr 29;11(2):e0014. doi: 10.5041/RMMJ.10400.
9
Principles of TAVR valve design, modelling, and testing.经导管主动脉瓣置换术瓣膜设计、建模和测试的原则。
Expert Rev Med Devices. 2018 Nov;15(11):771-791. doi: 10.1080/17434440.2018.1536427. Epub 2018 Oct 29.
10
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.机械扩张式与自膨胀式经导管主动脉瓣置换术对高危主动脉瓣狭窄患者死亡率和主要不良临床事件的影响:REPRISE III随机临床试验
JAMA. 2018 Jan 2;319(1):27-37. doi: 10.1001/jama.2017.19132.